Skip to content

Can early stage occupational therapeutic intervention reduce significantly the sick leave periods of selected incapacitated workers in daily practice of the medical officers in Belgium? A randomized controlled trial and cost-benefit analysis in members of Christelijke Mutualiteit (CM).

Can early stage occupational therapeutic intervention reduce significantly the sick leave periods of selected incapacitated workers in daily practice of the medical officers in Belgium? A randomized controlled trial and cost-benefit analysis in members of Christelijke Mutualiteit (CM).

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON21915
Enrollment
400
Registered
2013-06-05
Start date
2013-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sick leave days incapacity benefits occupational therapy medical officer musculoskeletal problems psychological problems psychosomatic problems

Interventions

1. Intake In a comprehensive intake-interview ( approximately 1 hour) the occupational therapist will elaborate the possible thresholds towards reintegration. This intake-interview is based on the IC

Sponsors

none
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age limits: lower limit is 16 years at the day of statement of their work inability and the upper limit is 60 years of statement of their work inability. Our study concerns that age cohort of the population with enough career perspective left. 2. Creating comparable groups the study population is limited to larger diagnostic groups : musculoskeletal problems, psychological problems, psychosomatic problems. The choice for these categories is also based on the studies and experience that individuals s with these diagnoses are more likely to drop out for a long time and that work related issues play often a significant role. (cfr Statistics Disability Riziv). 3. The trial includes only CM members who have a fix contract with an employer . This RTW (Return to work) trial is focused on people with a normal stable work relation that is on strain. 4. The individual has to cooperate and sent back a completed questionnaire IWC. The willingness to cooperate is an inclusion criterion for the study. 5. The individual estimates the likelihood to resume his/her work within three months from the first sick leave day lower than 10 on a 0 to 10 scale. Individuals who are from the beginning almost certain to resume their work without problems within those three months are not included. The study focuses on those cases who are in some way problematic in regard to work resumption. 6. The study includes only individuals who sent back to us the signed informed consent to participate in the study within the first three months of the sick leave period. We want to study early intervention and therefore we define a cut off point at three months.

Exclusion criteria

Exclusion criteria: 1. Sick leave by (industrial) accident; 2. Surgery (done or planned); 3. Psychiatric issue; 4. Insufficient understanding of Dutch language (all questionnaires are in Dutch); 5. Pregnancy; 6. Work inability has been refused from the beginning by the CM insurance physician; 7. Hospitalization; 8. Work already resumed or a communicated concrete plan to resume work.

Design outcomes

Primary

MeasureTime frame
1. What is the effectiveness of occupational therapeutic interventions among work disabled persons with psychic and/of musculoskeletal troubles on return to work RTW (= number of sick-leave days)? 2. What is the effectiveness of occupational therapeutic interventions among work disabled persons with psychic and/or musculoskeletal troubles on sustainable (lasting) work restart within 12 months?

Secondary

MeasureTime frame
1. What is the effectiveness of occupational therapeutic interventions among work disabled persons with psychic and/or musculoskeletal problems on their general wellbeing, resilience and self-efficacy after 6 and 12 months? 2. Can we define differences in outcome between the subgroups : musculoskeletal problems/ psychic problems/ psychosomatic problems ? 3. Can we define predictive variables influencing primary outcome?

Contacts

Public ContactRik Loenders

Prins-Bisschopssingel 75

rik.loenders@cm.be0032 (0)473 52 94 89

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)